New York State Teachers Retirement System Has $4.61 Million Holdings in Organon & Co. (NYSE:OGN)

New York State Teachers Retirement System decreased its holdings in Organon & Co. (NYSE:OGN - Free Report) by 5.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 308,888 shares of the company's stock after selling 18,988 shares during the quarter. New York State Teachers Retirement System owned approximately 0.12% of Organon & Co. worth $4,609,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Prospera Private Wealth LLC bought a new stake in shares of Organon & Co. in the third quarter worth $25,000. Horizon Bancorp Inc. IN grew its stake in shares of Organon & Co. by 2,401.5% in the fourth quarter. Horizon Bancorp Inc. IN now owns 1,651 shares of the company's stock worth $25,000 after purchasing an additional 1,585 shares during the last quarter. Versant Capital Management Inc grew its stake in shares of Organon & Co. by 92.2% in the fourth quarter. Versant Capital Management Inc now owns 2,760 shares of the company's stock worth $41,000 after purchasing an additional 1,324 shares during the last quarter. MassMutual Private Wealth & Trust FSB grew its stake in shares of Organon & Co. by 32.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 2,749 shares of the company's stock worth $41,000 after purchasing an additional 672 shares during the last quarter. Finally, Abich Financial Wealth Management LLC grew its stake in shares of Organon & Co. by 5,646.3% in the third quarter. Abich Financial Wealth Management LLC now owns 2,356 shares of the company's stock worth $45,000 after purchasing an additional 2,315 shares during the last quarter. Institutional investors own 77.43% of the company's stock.

Analysts Set New Price Targets

Several brokerages recently weighed in on OGN. Barclays reduced their price objective on shares of Organon & Co. from $26.00 to $24.00 and set an "overweight" rating on the stock in a research note on Friday, February 14th. TD Cowen upgraded shares of Organon & Co. to a "hold" rating in a report on Wednesday, January 15th. Finally, Morgan Stanley dropped their target price on shares of Organon & Co. from $17.00 to $16.00 and set an "equal weight" rating on the stock in a report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Organon & Co. has a consensus rating of "Hold" and an average target price of $20.80.

Organon & Co. Stock Down 1.4 %

Shares of NYSE OGN traded down $0.23 during trading on Friday, hitting $15.47. 3,552,714 shares of the company traded hands, compared to its average volume of 2,857,395. The business's fifty day moving average is $15.36 and its 200 day moving average is $17.31. Organon & Co. has a fifty-two week low of $13.87 and a fifty-two week high of $23.10. The firm has a market capitalization of $3.98 billion, a price-to-earnings ratio of 4.64, a P/E/G ratio of 0.85 and a beta of 0.76. The company has a debt-to-equity ratio of 17.73, a quick ratio of 1.21 and a current ratio of 1.70.

Organon & Co. (NYSE:OGN - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The company reported $0.83 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.09). Organon & Co. had a net margin of 13.49% and a return on equity of 431.62%. The company had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.57 billion. Equities research analysts predict that Organon & Co. will post 3.78 earnings per share for the current fiscal year.

Organon & Co. Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 13th. Stockholders of record on Monday, February 24th will be issued a dividend of $0.28 per share. The ex-dividend date of this dividend is Monday, February 24th. This represents a $1.12 annualized dividend and a dividend yield of 7.24%. Organon & Co.'s dividend payout ratio is currently 33.63%.

Organon & Co. Company Profile

Organon & Co is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.